Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
09/2003
09/03/2003EP0835139B1 Solid oral diagnostic test meal and methods of use thereof
09/03/2003EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4
09/03/2003EP0737209B1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
09/02/2003US6615063 Fluorescence-mediated molecular tomography
09/02/2003US6613894 Bonding the nucleoside to a solid support, deprotecting using an acid, reacting with a nucleoside phosphoramidite; oxidizing and coupling a biomolecule to the product
09/02/2003US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines
09/02/2003US6613306 Ultrasound contrast agents and methods of making and using them
09/02/2003US6613305 Radionuclide labeling of vitamin B12 and coenzymes thereof
08/2003
08/28/2003WO2003070752A2 Mhc-peptide complex binding ligands
08/28/2003WO2003070174A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
08/28/2003WO2003070173A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
08/28/2003WO2002101043A3 Regulation of human ta4 receptor
08/28/2003WO2002026776A3 Peptide-based compounds
08/28/2003US20030163036 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
08/28/2003US20030162963 Novel expanded porphyrins and process for the synthesis thereof
08/28/2003US20030162748 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162234 Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
08/28/2003US20030161883 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
08/28/2003US20030161788 System for monitoring bacterial tumor treatment
08/28/2003CA2476625A1 Mhc-peptide complex binding ligands
08/28/2003CA2476423A1 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
08/27/2003EP1337650A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337278A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337264A1 A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity
08/27/2003EP1337249A1 Compositions and methods for administration of pharmacologically active compounds
08/27/2003EP1112077A4 Method for detection of biological factors in epidermis
08/27/2003EP0702793B1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation
08/27/2003CN1438037A Supersonic contrast medium and supersonic contrast medium simultaneously as medicine and gene target carrier
08/27/2003CN1119173C Methods for preparing gas-filled liposomes
08/26/2003US6610850 Contrast media for angiography
08/26/2003US6610825 Method for alleviating pain or providing an analgesic effect in a patient
08/26/2003US6610722 Inhibitors of prenyl-protein transferase
08/26/2003US6610679 Use of green porphyrins to treat neovasculature in the eye
08/26/2003US6610547 Selection of contrast agent drug from a combinatorial library
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610270 In vivo determination of metabolic function for use in therapy management
08/26/2003US6610269 Disease state imaged using a targeted contrast agent of the formula V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker, R is a macromolecular or particulate label
08/26/2003US6610016 Echogenic coatings
08/21/2003WO2003068919A2 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/21/2003WO2003068787A1 Bi-functionalised metallocenes use for marking biological molecules
08/21/2003WO2003068269A1 Benzothiazole derivatives for in vivo imaging of amyloid plaques
08/21/2003WO2003068185A2 Use of buckysome or carbon nanotube for drug delivery
08/21/2003WO2003030951A3 Sampling article for determining quantitative and qualitative drug transfer to skin
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003011220A3 Animal model for fatty acid amide-related neurobehaviors
08/21/2003WO2003006070A3 Improved chelator conjugates
08/21/2003WO2002077236A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002022882A3 Target activated nucleic acid biosensor and methods of using same
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002020047A9 Chlamydial peptides and their mimics in demyelinating disease
08/21/2003WO2001097794A3 Inhibitors of matriptase for the treatment of cancer
08/21/2003US20030158258 5-aminolevulinic acid ester solution; detection of fluorescent protoporphyrin IX
08/21/2003US20030157585 Subjecting to in situ zymography a specimen isolated from a mammal that has received the compound exhibiting matrix metalloproteinase-inhibitory activity
08/21/2003US20030157327 Useful as distinct tagging agents or as encoders in procedures utilizing fluorescence-based detection such as microarrays, high-throughput screening, immunoassays, and flow cytometry
08/21/2003US20030157073 Methods for pretreating a subject with apoptotic cells
08/21/2003US20030157027 Administering mixture of biocompatibility polymer and contrast agent
08/21/2003US20030157026 Photodynamic diagnosis and therapy for insulin-dependent diabetes mellitus
08/21/2003US20030157025 Ultrasonic scanning
08/21/2003US20030157023 Ultrasonic diagnosis; gas filled microcapsules
08/21/2003US20030157021 Optical cohesion topography; medical diagnosis
08/21/2003CA2475924A1 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/21/2003CA2474411A1 Benzothiazole derivatives for in vivo imaging of amyloid plaques
08/20/2003EP1336654A1 Method of treating psoriasis using anti-gamma interferon antibody
08/20/2003EP1335937A2 Mixed fibrils
08/20/2003EP1102770B1 Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical preparations containing same, method for producing same and their use in magnetic resonance imaging of necrosis and infarction
08/20/2003EP0996469B1 Methods of photoacoustic imaging
08/20/2003EP0831926B1 Improvements in or relating to contrast agents
08/19/2003US6608186 Pyranosyl nucleic acid conjugates
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608029 Reducing gastric motility or delaying gastric emptying in mammal by administering therapeutically effective amount of amylin or amylin agonist, such as pramlintide or pramlintide acetate
08/19/2003CA2091165C Polymers containing diester units
08/19/2003CA2073482C Nuclear magnetic resonance imaging agent
08/14/2003WO2003066862A1 Cloning of a human prolylhydroxylase-like protein
08/14/2003WO2003066038A1 Process to prepare semicarbazones’ and/or tiosemicarbazones’ formulations using cyclodextrins and their derivatives and products obtained by this process
08/14/2003WO2003066021A2 Drug nanoparticles with lysozyme surface stabiliser
08/14/2003WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
08/14/2003WO2003065971A2 Non-myeloablative tolerogenic treatment with tyrphostins
08/14/2003WO2003065888A1 Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications
08/14/2003WO2003065882A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
08/14/2003WO2003065806A1 New immunoeffector compounds
08/14/2003WO2003045432A8 Treatment of neovascular ophthalmic disease
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003013346A3 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
08/14/2003WO2002081430A3 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153736 Diagnosis and prognosis and radiotherapy of metastatic bone disease
08/14/2003US20030153734 Via chromatography of immobilized tissue extracts through molecular sieves; animal models; amyloid precursor proteins
08/14/2003US20030153603 Agent for enhancing accumulation of drugs in tumor tissues
08/14/2003US20030152622 Formulation of an erodible, gastric retentive oral diuretic
08/14/2003US20030152618 Immobilized unto polyoxyethylene glycol
08/14/2003US20030152579 Controlling biosynthesis of hybrid protein; therapy against Helicobacter infections
08/14/2003US20030152577 Antitumor agents; anticancer agents; cyanine dye complex
08/14/2003US20030152519 Evaluating the perfusion status of organs on the level of the smallest blood vessels (i.e. capillaries).
08/14/2003US20030152518 Detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells.
08/14/2003US20030152516 Methods for imaging pulmonary and cardiac vasculature and evaluating blood flow using dissolved polarized 129Xe
08/14/2003US20030152515 Method for estimating effective regimens and patient survival rates of antibiotic treatments for fatal infectious diseases
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 354